trending Market Intelligence /marketintelligence/en/news-insights/trending/eCZim__Gt2u-a558m05YPA2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Amgen amends, extends lease at Healthpeak's San Francisco property

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

The Commercial Real Estate CRE Sector Feels the Impact of the Coronavirus

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Amgen amends, extends lease at Healthpeak's San Francisco property

Amgen Inc. entered into a lease amendment and extension at Healthpeak Properties Inc.'s Britannia Oyster Point property in South San Francisco.

The healthcare real estate investment trust said the biotechnology company already leases space across seven of the 10-building campus, which offers a total of more than 900,000 square feet of class A life sciences space.

Under the amended lease, Amgen will continue to occupy 257,000 square feet in the three buildings at 1100, 1120 and 1140 Veterans Blvd. through December 2029, extended from a prior lease expiration of December 2021, with the right to terminate 68,000 square feet in 2022 and 189,000 square feet in 2024.

The respective December 2021 and December 2023 expiration dates will remain unchanged for Amgen's 176,000-square-foot lease in the two buildings at 1130 and 1150 Veterans Blvd. and its 251,000-square-foot lease in the buildings at 331 and 333 Oyster Point Blvd.

Healthpeak said it has the right to terminate Amgen's lease for 81,250 square feet at the 1130 and 1150 Veterans Blvd. buildings in March 2021.